Duchenne Muscular Dystrophy Market on Track to Surpass US$ 7.4 Billion by 2034 at CAGR of 11.7% | Analysis by Transparency Market Research, Inc.

Owing to the deficiency of a protein called dystrophin, the muscles of an individual are weakened, resulting in progressive muscle degeneration, which is called Duchenne muscular dystrophy. This medical disorder can be attributed to one of four conditions called dystrophinopathies….

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.